Navidea biopharmaceuticals reports q2 loss per share of $0.11

Navidea biopharmaceuticals reports second quarter and year-to-date 2020 financial results.q2 revenue $271,000 versus $260,000.q2 loss per share $0.11.
NAVB Ratings Summary
NAVB Quant Ranking